MASS Utang jangka cendhak marang modal 908 Devices Inc.

Tandha merek 908 Devices Corp (MASS)

Revenue growth for 908 Devices Inc. (MASS) is driven by the implementation of mobile analyzers in forensics and biotechnology, as well as the sale of software and consumables. US plants produce instruments for the rapid chemical analysis of medicine and science. This chart illustrates the dynamics of the indicator, which stands at 0.00. Meanwhile, high R&D and logistics costs are constraining the rapid scaling of operating profit.

MASS - Tanggungan utang jangka cendhak marang ekuitas 908 Devices Corp ing rentang 04.07.2022 - 29.10.2026
Produk mawa merek 908 Devices

908 Devices Inc. is transforming its operating model from a startup to systemic sales scaling. An analysis of the short-term liabilities-to-equity ratio allows for an assessment of the company's current debt load. This indicator measures the share of short-term obligations (over one year) within the equity structure, reflecting the level of financial leverage. This helps investors determine business stability and the efficiency of debt management amid revenue growth.

Pesaing wigati

Utang jangka cendhak marang modal ABT|Koefisien utang jangka cendhak marang modal Thermo Scientific|Utang jangka cendhak marang modal GEHC (GE HealthCare)|Utang jangka cendhak marang modal mt.com MTD|Waters - Utang jangka cendhak marang modal|Tanggungan utang jangka cendhak marang ekuitas Bio-Techne Corp (TECH)|Bruker Corp. (BRKR) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang modal AZTA|Utang jangka cendhak marang ekuitas Varex Imaging|Kewajiban jangka cendhak marang modal semlerscientific.com SMLR|Utang jangka cendhak marang ekuitas Butterfly Network (BFLY)|Koefisien utang jangka cendhak marang modal Mesa Laboratories Inc|Quantum-Si Corp - Rasio utang jangka cendhak marang ekuitas|Rasio silihan jangka cendhak marang modal NNOX (Nano-X Imaging Ltd)|Quanterix Corporation - Utang jangka cendhak marang modal|Koefisien utang jangka cendhak marang modal CapsoVision Inc CV|MXCT: Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas Rapid Micro Biosystems, Inc.|Rasio utang jangka cendhak marang ekuitas SEER|HYPR: Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas FONAR Corporation (FONR)|Rasio utang jangka cendhak marang ekuitas daxor.com DXR|Utang jangka cendhak marang modal MDAI (Spectral AI, Inc.)|Organovo Holdings Inc. (VIVS) - Kewajiban jangka cendhak marang modal|Aclarion Corp - Utang jangka cendhak marang modal|AKYA (Akoya Biosciences) - Rasio utang jangka cendhak marang modal|THMO: Utang jangka cendhak marang modal|TLIS - Koefisien utang jangka cendhak marang modal|TTOO (T2 Biosystems) - Utang jangka cendhak marang modal